Rheumatoid Arthritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid Interventions: Drug: Placebo; Drug: Nipocalimab; Drug: Certolizumab Sponsor: Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials